The clinical trial includes evaluating tolerability, immunogenicity, and safety of two intramuscular vaccinations for HIV-infected children
U.S. headquartered clinical-stage biopharmaceutical company, Curevo Vaccine has attained an approval for initiating a Phase 1b clinical trial of its investigat